X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (579) 579
Publication (42) 42
Patent (23) 23
Book Chapter (9) 9
Book / eBook (4) 4
Conference Proceeding (4) 4
Book Review (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (344) 344
hematology (254) 254
female (216) 216
male (205) 205
middle aged (193) 193
adult (180) 180
aged (153) 153
index medicus (145) 145
adolescent (82) 82
aged, 80 and over (78) 78
essential thrombocythemia (78) 78
oncology (76) 76
risk factors (73) 73
thrombosis (67) 67
polycythemia-vera (65) 65
prognosis (55) 55
mutation (52) 52
thrombosis - etiology (50) 50
myeloproliferative disorders (49) 49
janus kinase 2 - genetics (44) 44
polycythemia vera (44) 44
risk (43) 43
therapy (42) 42
treatment outcome (42) 42
leukemia (39) 39
abridged index medicus (38) 38
hydroxyurea (36) 36
diagnosis (34) 34
myeloproliferative neoplasms (34) 34
follow-up studies (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
polycythemia vera - complications (32) 32
child (31) 31
thrombocythemia, essential - complications (31) 31
hydroxyurea - therapeutic use (30) 30
myelofibrosis (30) 30
retrospective studies (30) 30
young adult (28) 28
polycythemia (27) 27
polycythemia vera - drug therapy (27) 27
thrombocythemia, essential - drug therapy (26) 26
thrombocythemia, essential - genetics (26) 26
polycythemia vera - blood (25) 25
polycythemia vera - therapy (25) 25
platelet count (23) 23
polycythemia vera - genetics (23) 23
disease-free survival (22) 22
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
preparations for medical, dental, or toilet purposes (22) 22
survival (22) 22
classification (21) 21
expression (21) 21
medicine, general & internal (21) 21
pregnancy (21) 21
peripheral vascular disease (20) 20
prospective studies (20) 20
remission induction (20) 20
survival analysis (20) 20
survival rate (20) 20
anticardiolipin antibodies (19) 19
antineoplastic agents - therapeutic use (19) 19
disease progression (19) 19
hematocrit (19) 19
myeloproliferative disorders - complications (19) 19
phlebotomy (19) 19
thrombosis - prevention & control (19) 19
tumors (19) 19
cancer (18) 18
care and treatment (18) 18
chemotherapy (18) 18
cohort studies (18) 18
hemic and lymphatic diseases (18) 18
leukocytosis (18) 18
management (18) 18
platelet aggregation inhibitors - therapeutic use (18) 18
polycythemia vera - diagnosis (18) 18
thrombocythemia, essential - blood (18) 18
thrombocythemia, essential - diagnosis (18) 18
tyrosine kinase jak2 (18) 18
aspirin (17) 17
primary myelofibrosis - diagnosis (17) 17
complications (16) 16
hematopoietic stem cell transplantation (16) 16
thrombosis - epidemiology (16) 16
aspirin - therapeutic use (15) 15
international working group (15) 15
jak2 (15) 15
jak2 v617f mutation (15) 15
myeloproliferative disorders - drug therapy (15) 15
neoplasms. tumors. oncology. including cancer and carcinogens (15) 15
polycythemia vera - pathology (15) 15
time factors (15) 15
acute disease (14) 14
acute myeloid-leukemia (14) 14
analysis (14) 14
child, preschool (14) 14
cyclophosphamide - administration & dosage (14) 14
medical and health sciences (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (602) 602
Italian (10) 10
French (5) 5
German (4) 4
Korean (3) 3
Portuguese (2) 2
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 894 - 896
To the Editor: In his article on myeloproliferative neoplasms, Spivak (June 1 issue)1 briefly addresses the diagnostic effect of morphologic features and... 
Genotype & phenotype | Leukemia | Erythrocytes | Stem cells | Bone marrow | Mutation | Tumors
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2017, Volume 92, Issue 1, pp. 94 - 108
Disease overview Polycythemia Vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively characterized by erythrocytosis and... 
ACUTE-LEUKEMIA | JAK2(V617F) MUTATION | MYELOFIBROSIS RESEARCH | LOW-DOSE ASPIRIN | LONG-TERM SURVIVAL | MYELOPROLIFERATIVE NEOPLASMS | CALRETICULIN MUTATIONS | DEFINED ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | INTERFERON-ALPHA THERAPY | INTERNATIONAL WORKING GROUP | Primary Myelofibrosis - mortality | Humans | Polycythemia Vera - blood | Polycythemia Vera - genetics | Primary Myelofibrosis - pathology | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Aspirin - administration & dosage | Erythropoietin - blood | Thrombocytosis - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aspirin - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Thrombocytosis - pathology | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - diagnosis | Diagnosis, Differential | Risk Assessment | Interferon-alpha - therapeutic use | Janus Kinase 2 - genetics | Hydroxyurea - administration & dosage | Thrombocythemia, Essential - blood | Polycythemia Vera - diagnosis | Thrombocytosis - diagnosis | Interferon-alpha - administration & dosage | Receptors, Thrombopoietin - genetics | Thrombocythemia, Essential - diagnosis | Hydroxyurea - therapeutic use | Polycythemia Vera - drug therapy | Mutation | Erythropoietin | Polycythemia | Leukemia | Diagnosis | Tumor proteins | Thrombosis | Risk factors | Blood clot
Journal Article
Blood, ISSN 0006-4971, 09/2013, Volume 122, Issue 13, pp. 2176 - 2184
Major causes of morbidity and mortality in myeloproliferative neoplasms are represented by arterial and venous complications, progression to myelofibrosis, and... 
Myeloproliferative Disorders - complications | Thrombosis - etiology | Humans | Risk Factors
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2019, Volume 94, Issue 1, pp. 133 - 143
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively characterized by erythrocytosis and... 
ACUTE-LEUKEMIA | MYELOFIBROSIS RESEARCH | PRIMARY PROLIFERATIVE POLYCYTHEMIA | LOW-DOSE ASPIRIN | HYDROXYUREA | MYELOPROLIFERATIVE NEOPLASMS | YOUNG-PATIENTS | DEFINED ESSENTIAL THROMBOCYTHEMIA | HEMATOLOGY | ALLELE BURDEN | INTERNATIONAL WORKING GROUP
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2017, Volume 92, Issue 1, pp. 94 - 108
Journal Article
Leukemia, ISSN 0887-6924, 05/2018, Volume 32, Issue 5, pp. 1057 - 1069
This document updates the recommendations on the management of Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-neg MPNs) published in 2011 by... 
CALR MUTATIONS | TRANSFUSION-DEPENDENCY | ERYTHROPOIESIS-STIMULATING AGENTS | WORKING GROUP | POST-POLYCYTHEMIA-VERA | ONCOLOGY | CYTOGENETIC-RISK CATEGORIZATION | OPEN-LABEL | ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS | HEMATOLOGY | INTERNATIONAL PROGNOSTIC SCORE | MYELOID METAPLASIA | Myeloproliferative Disorders - diagnosis | Pyrazoles - therapeutic use | Splenomegaly - drug therapy | Myeloproliferative Disorders - therapy | Europe | Humans | Neoplasms - diagnosis | Randomized Controlled Trials as Topic | Neoplasms - therapy | Stem Cell Transplantation - methods | Disease Management | Myeloproliferative Disorders - complications | Philadelphia Chromosome | Splenomegaly | Transfusion | Transplants & implants | Hematocrit | Clinical trials | Stem cell transplantation | Risk | Polycythemia vera | Hydroxyurea | Transplantation | Neoplasms | Consortia | α-Interferon | Randomization | Polycythemia | Quality | Janus kinase 2 | Peripheral blood | Bone marrow | Hemoglobin | Janus kinase | Diagnosis | Recombinant | Myelofibrosis | Risk groups | Anemia | Health risks | Patients | Philadelphia chromosome | Stem cells | Cytogenetics | Interferon | Diagnostic systems | Mutation | Tumors | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Klinisk medicin | Cancer and Oncology | Cancer och onkologi
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 9, pp. 787 - 798
Journal Article